YOLFTbeta
Sotera Health Co

Sotera Health Co

SHC · NASDAQ · Healthcare / Diagnostics & Research

16.61USD+0.31 (+1.90%)

Price History

Full chart

Market Stats

Previous Close16.30
Open16.39
Day Range16.15 – 16.65
52-Week Range13.09 – 19.85
Volume2.65M
Market Cap5.06B
P/E (TTM)31.12
Forward P/E17.64
EPS0.57
Dividend Yield0.00%
Beta1.93
50-Day Avg18.52
200-Day Avg17.00

About

Sotera Health Company provides sterilization solutions, lab testing, and advisory services for the healthcare industry in the United States, Canada, Europe, and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. The Sterigenics segment offers outsourced terminal sterilization and irradiation services using gamma irradiation, ethylene oxide processing, and electron beam irradiation technologies for medical devices, pharmaceutical, and food safety and advanced applications markets. The Nordion segment provides Cobalt-60 used in the sterilization and irradiation processes for the medical device, pharmaceutical, food safety, and high-performance materials industries, as well as in the treatment of cancer. It also offers gamma irradiation systems. The Nelson Labs segment provides outsourced microbiological and analytical chemistry testing and advisory services for the medical device and pharmaceutical industries. The company was formerly known as Sotera Health Topco, Inc. and changed its name to Sotera Health Company in October 2020. Sotera Health Company was incorporated in 2015 and is headquartered in Broadview Heights, Ohio.

Company Details

  • SectorHealthcare
  • IndustryDiagnostics & Research
  • CEOMr. Alton E. Shader
  • Employees3.00K
  • Headquarters9100 South Hills Blvd, Broadview Heights, OH, United States, 44147, USA
  • Websitehttps://soterahealth.com

Leadership

  • Mr. Michael B. Petras Jr.Executive Chairman of the Board · b. 1969
  • Mr. Jonathan M. LyonsSenior VP & CFO · b. 1978
  • Mr. Michael P. RutzPresident of Sterigenics U.S., LLC · b. 1971
  • Mr. Alton E. ShaderCEO & Director · b. 1973
  • Mr. Robert G. HauzieChief Information Officer
  • Ms. Erika OstrowskiSenior VP, General Counsel & Corporate Secretary
  • Ms. Kristin A. GibbsChief Marketing Officer
  • Mr. William O. Lehmann Jr., J.D., M.B.A.Senior Vice President of Strategy & Corporate Development · b. 1966
  • Ms. Sally R. TurnerChief Human Resources Officer
  • Ms. Danielle J. MentureSenior Vice President of Global Environmental, Health & Safety and Sustainability

Financials

Income Statement

Currency: USD1997-12-311998-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue--746.15M778.33M818.16M931.48M1.00B1.05B1.10B1.16B
Growth (%)---+4.31%+5.12%+13.85%+7.75%+4.54%+4.88%+5.74%
Cost of Revenue--388.90M382.90M374.59M412.81M446.68M472.13M498.15M518.08M
Gross Profit--357.25M395.43M443.57M518.67M557.00M577.16M602.29M645.53M
Gross Margin--47.88%50.81%54.22%55.68%55.50%55.00%54.73%55.48%
Operating Expense--276.40M211.83M237.55M261.94M308.65M300.47M304.67M252.76M
Operating Income--80.85M183.60M206.02M256.73M248.35M276.69M297.63M392.77M
Operating Margin--10.84%23.59%25.18%27.56%24.74%26.37%27.05%33.75%
EBITDA--314.36M303.53M319.96M400.81M-17.41M406.83M442.20M442.25M
EBITDA Margin--42.13%39.00%39.11%43.03%-1.73%38.77%40.18%38.01%
Net Income---5.87M-20.85M-38.62M116.88M-233.57M51.38M44.40M77.95M
Net Income Margin---0.79%-2.68%-4.72%12.55%-23.27%4.90%4.03%6.70%
Interest Expense00143.33M157.73M215.26M74.19M80.14M142.88M164.69M155.72M
Interest Expense % of Total Revenue--19.21%20.27%26.31%7.96%7.98%13.62%14.97%13.38%

Balance Sheet

Currency: USD1997-12-311998-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets--2.71B2.58B2.76B2.79B3.12B3.13B3.07B3.26B
Total Liabilities--2.66B3.22B2.31B2.20B2.77B2.69B2.67B2.66B
Total Equity--44.36M-642.57M452.30M586.10M350.24M443.73M404.91M606.03M
Cash--96.27M62.86M102.45M106.92M395.21M296.41M277.24M346.46M
Total Debt--2.24B2.85B1.91B1.83B2.03B2.33B2.35B2.27B
Net Debt--2.14B2.79B1.81B1.72B1.64B2.03B2.07B1.93B

Cash Flow

Currency: USD1997-12-311998-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow13.31M18.19M119.56M149.04M120.58M281.55M277.96M-147.73M224.16M287.19M
Investing Cash Flow-33.50M-5.55M96.64M-57.26M-158.69M-159.83M-181.90M-214.91M-179.00M-135.14M
Financing Cash Flow--2.58M-191.86M-126.03M73.43M-117.29M197.76M265.96M-50.56M-100.53M
Capital Expenditure022.61M72.61M57.26M53.51M102.16M182.38M214.97M179.07M138.02M
Free Cash Flow--46.95M91.78M67.08M179.38M95.58M-362.71M45.09M149.18M
Dividends Paid-175.84M175.84M691.17M150.00M0----
FCF to OCF--39.27%61.58%55.63%63.71%34.39%245.52%20.12%51.94%
Dividend Paid to FCF--374.54%753.04%223.62%0.00%----

Earnings

Report DateMar 31, 2019Jun 30, 2019Sep 30, 2019Mar 31, 2020Jun 30, 2020Sep 30, 2020Nov 19, 2020Mar 9, 2021May 13, 2021Aug 12, 2021Nov 10, 2021Mar 1, 2022May 5, 2022Aug 4, 2022Nov 2, 2022Feb 28, 2023May 3, 2023Aug 3, 2023Nov 1, 2023Feb 27, 2024May 2, 2024Aug 5, 2024Nov 5, 2024Feb 25, 2025May 1, 2025Aug 8, 2025Nov 4, 2025Feb 24, 2026May 5, 2026Aug 6, 2026Nov 3, 2026
EPS Estimate0.000.000.000.000.000.000.080.070.160.210.200.220.200.240.220.220.140.170.200.260.120.160.180.200.120.170.220.240.170.220.24
EPS Actual0.030.03-0.020.010.010.000.020.090.180.260.210.230.220.270.230.250.130.210.210.260.130.190.170.210.140.200.260.260.180.240.29
Surprise-------75.00%28.57%12.50%23.81%5.00%4.55%10.00%12.50%4.55%13.64%-7.14%23.53%5.00%0.00%8.33%18.75%-5.56%4.01%16.67%17.65%18.18%7.35%5.88%9.09%20.83%
Timing------After-hoursPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-market-Pre-marketPre-marketPre-market

Key Statistics & Ratios

Market Cap5.06B
Enterprise Value7.09B
Trailing P/E31.12
Forward P/E17.64
PEG Ratio1.68
Price / Sales4.16
Price / Book7.78
EPS0.57
Book Value2.33
Revenue (TTM)1.22B
Gross Profit (TTM)668.51M
EBITDA576.58M
Profit Margin13.44%
Operating Margin37.96%
Return on Equity27.78%
Return on Assets8.60%
Shares Outstanding285.37M
Shares Float200.85M
Beta1.93
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Analyst Ratings

Buy
Based on 10 analystsTarget 22.61
  • Strong Buy
    5
  • Buy
    3
  • Hold
    1
  • Sell
    1

Ownership Breakdown

Institutions
101.28%
Insiders
2.40%
Retail / Other
0.00%

Top Institutional Holders

  • Sessa Capital, L.P
    27.05M9.48%
  • Darsana Capital Partners LP
    27.00M9.46%
  • BlackRock Inc
    24.15M8.46%
  • OZ Management LLC
    24.00M8.41%
  • Sachem Head Capital Management LP
    15.56M5.45%
  • Vanguard Capital Management, LLC
    12.17M4.26%
  • Vanguard Portfolio Management, LLC
    11.95M4.19%
  • AQR Capital Management LLC
    10.73M3.76%
  • T. Rowe Price Investment Management,Inc.
    10.52M3.69%
  • Jupiter Topco LLC
    8.40M2.94%
  • State Street Corp
    8.32M2.92%
  • FMR Inc
    6.17M2.16%
  • Voss Capital LLC
    5.83M2.04%
  • Dimensional Fund Advisors, Inc.
    5.80M2.03%
  • Geode Capital Management, LLC
    5.22M1.83%
  • Irenic Capital Management LP
    5.14M1.80%

Top Fund Holders

  • iShares Core S&P Mid-Cap ETF
    10.25M3.59%
  • Vanguard MStar Total Stk Mkt Idx Invest
    8.67M3.04%
  • Vanguard Small Cap Index
    6.10M2.14%
  • Janus Henderson Contrarian D
    5.85M2.05%